Investing.com – European stock markets were down on Monday, as drugmakers slipped after the House of Representatives approved a far-reaching overhaul of the U.S. healthcare system.
During early European trade, France’s CAC 40 was down 0.62%; Germany's DAX slipped 0.48%; Britain's FTSE 100 was down 0.63%; and the EURO STOXX 50 shed 0.67%.
Pharmaceutical companies were among the worst performers, with Sanofi-Aventis dropping 1.38% and Roche shedding 0.8%, after House Democrats approved the health care reform, voting over Republican opposition to provide tens of millions of uninsured Americans with medical coverage.
Persisting concerns over Greece also hurt investor sentiment, as European leaders remained divided on whether their nations should provide the debt-laden country with financial aid.
The outlook for U.S. markets, meanwhile, was also dim: Dow Jones Industrial Average futures indicated a drop of 0.38%, S&P 500 Index futures pointed to a slide of 0.44% and Nasdaq 100 Index futures indicated a decline of 0.33%.
Later in the day, the European Central Bank president, Jean-Claude Trichet, was set to testify before the Economic and Monetary Affairs Committee of the European Parliament in Brussels.
During early European trade, France’s CAC 40 was down 0.62%; Germany's DAX slipped 0.48%; Britain's FTSE 100 was down 0.63%; and the EURO STOXX 50 shed 0.67%.
Pharmaceutical companies were among the worst performers, with Sanofi-Aventis dropping 1.38% and Roche shedding 0.8%, after House Democrats approved the health care reform, voting over Republican opposition to provide tens of millions of uninsured Americans with medical coverage.
Persisting concerns over Greece also hurt investor sentiment, as European leaders remained divided on whether their nations should provide the debt-laden country with financial aid.
The outlook for U.S. markets, meanwhile, was also dim: Dow Jones Industrial Average futures indicated a drop of 0.38%, S&P 500 Index futures pointed to a slide of 0.44% and Nasdaq 100 Index futures indicated a decline of 0.33%.
Later in the day, the European Central Bank president, Jean-Claude Trichet, was set to testify before the Economic and Monetary Affairs Committee of the European Parliament in Brussels.